Výsledky vyhledávání - "Mohammed Benlahfid"

Akademický článek

Épidémiologie descriptive de la carcinose péritonéale d'origine digestive à l'Hôpital Universitaire Ibn Rochd de Casablanca (2008-2010)

Autor: Mohammed Benlahfid, Driss Erguibi, Khalid Elhattabi, Fatimazahra Bensardi, Driss Khaiz, Rachid Lafriekh, Dounia Rebroub, Abdelaziz Fadi, Touria Aboussaouira

Publikováno v: The Pan African Medical Journal, Vol 27, Iss 234 (2017)

INTRODUCTION: La carcinose péritonéale est une diffusion inéluctablement terminale chez les patients atteints de cancers abdominaux. C'est le signe d'une maladie avancée ou d'une ré-évolution le plus souvent associée à un pronostic sombre. En

Externí odkaz: https://doaj.org/article/073251afbf5e4ddbac30be4239602f6e

Zobrazit plný text záznamu

Epidemiological Profile and Risk Factors of Ovarian Cancer in Ibn Rochd University Hospital of Casablanca Morocco: About 131 Cases

Autor: Benfateh Meriem, Abdellatif Benider, Mohammed Benlahfid, Nadia Alfaidy, Souha Sahraoui, Touria Aboussaouira

Publikováno v: Clinical Oncology and Research. :1-4

Introduction: Ovarian cancer is one of the leading causes of morbidity and mortality in women worldwide, generally characterized by a poor prognosis. Most cases are diagnosed at an advanced stage. The standardized incidence rate for the world populat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fff6cd57623a9ab9e228439dbade484
https://doi.org/10.31487/j.cor.2020.06.16

Zobrazit plný text záznamu

Vascular endothelial growth factor (VEGF) and Endocrine gland-VEGF (EG-VEGF) are down regulated in head and neck cancer

Autor: Mohammed Benlahfid, Wael Traboulsi, Nadia Alfaidy, Mustapha Sidqui, Mohamed Benharouga, Touria Aboussaouira, Si Mohamed Bouzoubaa, Chouaib Rifki, Sophie Brouillet

Publikováno v: Clinical Otolaryngology
Clinical Otolaryngology, Wiley-Blackwell, 2020, 45 (5), pp.788-795
Clinical Otolaryngology, 2020, 45 (5), pp.788-795. ⟨10.1111/coa.13595⟩

International audience; Objective To characterise the role of VEGF, EG-VEGF and its receptors in the development and progression of HNC. Design Human serum and tissues samples were collected from healthy, epulis and HNC patients and used for ELISA as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548078f9e275588cf2e4742f5bc3b5cf
https://hal.archives-ouvertes.fr/hal-02914409

Zobrazit plný text záznamu

Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis

Autor: Abdelaziz Fadil, Mohammed Benlahfid, Mohamed Benharouga, Driss Erguibi, Mehdi Karkouri, Khalid Elhattabi, Hicham Elattar, Wael Traboulsi, Yassine Fahmi, Frederic Sergent, Nadia Alfaidy, Touria Aboussaouira

Publikováno v: Cancer Biomarkers
Cancer Biomarkers, IOS Press, 2018, 21 (2), pp.345-354. ⟨10.3233/CBM-170499⟩
Cancer Biomarkers, 2018, 21 (2), pp.345-354. ⟨10.3233/CBM-170499⟩

International audience; BACKGROUND:The highest risk factor for mortality among malignant tumors is metastasis. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an angiogenic factor which biological activity is mediated via two

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523bad963e16c98cd43732e2b7010ffd
https://doi.org/10.3233/cbm-170499

Zobrazit plný text záznamu

Plný text ve formátu HTML

The Ciliate Protist Tetrahymena pyriformis as a Cellular Adhesion Model for the Pathogenic Bacterium Staphylococcus aureus

Autor: Mohammed Benlahfid, Bouchra El Khalfi, Nezha Senhaji, Abdelaziz Soukri, Sofia Jarmouni, Aurelio Serrano Delgado

Publikováno v: Advances in Bioscience and Biotechnology. :491-507

Staphylococcus aureus is one of the main pathogenic agents responsible for nosocomial and community-acquired bacterial infections. The pathogenicity of this Gram-positive bacterium is ensured by its different adhesion factors. Collagen and the extrac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f7c7db0b7adc33f90f25711e1b48d4a2
https://doi.org/10.4236/abb.2017.812036

Zobrazit plný text záznamu

Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression In Vitro and In Vivo

Autor: Touria Aboussaouira, Rima Slim, Pierre Adrien Bolze, François Mallet, Nadia Alfaidy, Philippe Sauthier, Houssine Boufettal, Jean-Jacques Feige, Sophie Brouillet, Mohamed Benharouga, Aude Salomon, Wael Traboulsi, Valentina Onnis, Mohammed Benlahfid, Frederic Sergent, Gianfranco Balboni, Qun-Yong Zhou, Pascale Hoffmann

Publikováno v: Clinical Cancer Research
Clinical Cancer Research, 2017, 23 (22), pp.7130-7140. ⟨10.1158/1078-0432.CCR-17-0811⟩
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (22), pp.7130-7140. ⟨10.1158/1078-0432.CCR-17-0811⟩
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (22), pp.7130-7140. 〈10.1158/1078-0432.CCR-17-0811〉

Purpose: Choriocarcinoma (CC) is the most malignant gestational trophoblastic disease that often develops from complete hydatidiform moles (CHM). Neither the mechanism of CC development nor its progression is yet characterized. We recently identified

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebc7b870067c9befd0ff74d1106ec91
https://hal.science/hal-01633971

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání